Arrowhead Pharmaceuticals (ARWR) had the highest return since June 30, 2001 and in August 2002 by a large-cap US stock, returning 100%.
| ASSET | % RETURN |
|---|---|
Arrowhead Pharmaceuticals (ARWR) | 100% |
NetEase (NTES) | 74.59% |
Crown (CCK) | 66.29% |
MicroStrategy (MSTR) | 63.86% |
Service Corporation International (SCI) | 63.17% |
AES (AES) | 51.01% |
Hecla Mining (HL) | 50% |
Eldorado Gold (EGO) | 48.92% |
Harmony Gold Mining (HMY) | 39.01% |
Agnico Eagle Mines (AEM) | 38.42% |
Royal Gold (RGLD) | 37.5% |
Quanta Services (PWR) | 37.31% |
Xcel Energy (XEL) | 37.02% |
Telus (TU) | 36.94% |
Coeur Mining (CDE) | 36.55% |
Itau Unibanco Banco (ITUB) | 35.66% |
CNH Industrial (CNH) | 33.32% |
CMS Energy (CMS) | 32.2% |
Kinross Gold (KGC) | 28.39% |
Cheniere Energy (LNG) | 28% |
Align Technology (ALGN) | 27.66% |
Novo Nordisk A-S (NVO) | 27.22% |
Axon Enterprise (AXON) | 26.72% |
Corning (GLW) | 26.58% |
Pan American Silver (PAAS) | 24.61% |
Large-cap stocks are treated as having a market cap of $10B+.